98
Participants
Start Date
October 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Certolizumab pegol
Auto-injection device (test) containing 1 mL of certolizumab pegol liquid formulation, 200 mg/mL; 2 injections
Certolizumab pegol
Pre-filled syringe (reference) containing 1 mL of certolizumab pegol liquid formulation, 200 mg/mL; 2 injections
Rennes
Lead Sponsor
UCB Pharma
INDUSTRY